Toxic narratives: Farmers with Parkinson’s Disease in the foothills of Kilimanjaro
Objective: To investigate the toxicological and epidemiologic perspective on pesticide exposure in Parkinson’s Disease in an exceptional region. Background: In most lower income countries (LIC)…Genome-wide Discovery of Genetic Modifiers of LRRK2 risk in Parkinson’s Disease Carriers across European Populations
Objective: To identify genetic risk modifiers for LRRK2 variant carriers of European ancestry. Background: The LRRK2 p.G2019S variant is associated with substantially elevated risk for…Pain Assessment using Parkinson’s Disease Pain Classification System (PD-PCS) and King’s Parkinson Disease Pain Scale (KPPS) – a Comparative Study
Objective: To evaluate and compare the applicability of KPPS and the PD-PCS in patients with Parkinson’s disease Background: Pain assessment in PD remains a relevant…Treatment Patterns in Parkinson’s Disease in Kyrgyzstan: Evidence from a Kyrgyz PD Cohort
Objective: To characterize treatment patterns and access to antiparkinsonian medications among patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: Access to treatment for PD remains…Cholinergic dysfunction associated to aberrant functional connectivity in Parkinson Disease-related dystonia
Objective: Assess presynaptic cholinergic integrity and associated functional connectivity differences in Parkinson disease (PD)-related dystonia. Background: Dystonia is observed in 30-60% of individuals with PD.…Correlations Between Clinical Variables And Cerebral Perfusion in Parkinson’s Disease With Mild Cognitive Impairment: A Multi-Delay pcASL Study
Objective: To evaluate whether partial volume–corrected cerebral blood flow (pvCBF), with and without additional spatial smoothing (5 mm), improves detection of perfusion differences and clinical…Efficacy and Safety of GLP-1 Receptor Agonists in Parkinson’s Disease: A Meta-Analysis Integrating the 96-Week Phase 3 Exenatide Trial Results
Objective: To evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists in patients with Parkinson’s disease (PD) through an updated systematic review and meta-analysis…Occupational Solvent Exposure and Parkinson’s Disease: An Observational Study in PPMI Online
Objective: To investigate the association between occupational solvent exposure and Parkinson’s disease using data from the PPMI Online cohort. Background: Environmental toxicant exposure has been…Urate Levels and Risk of Parkinson’s Disease：A Two-Sample Mendelian Randomization Study
Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…Evaluating Parkinson’s Disease Telehealth in Residential Aged Care
Objective: To evaluate the use, barriers, outcomes, and clinician perspectives of specialist telehealth for Parkinson’s disease (PD) care in residential aged care facilities. Background: Specialist…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 553
- Next Page »